Patent · US Active

Isolated 3′-noncoding genomic human resistin polynucleotide fragments

US8372588B1 · kind B1 · utility

0Cited by
2References
18Claims
0Family size

Assignee

Inventor

Key dates

Filing dateSep 3, 2011
Grant dateFeb 12, 2013
Priority date
Expiry dateSep 3, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K14/4716
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The invention is directed to isolated genomic polynucleotide fragments that encode human resistin and human syntaxin binding protein 2, vectors and hosts containing these fragments and fragments hybridizing to noncoding regions as well as antisense oligonucleotides to these fragments. The invention is further directed to methods of using these fragments to obtain human resistin and human syntaxin binding protein 2 and to diagnose, treat, prevent and/or ameliorate a pathological disorder.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.